Li, R., Tian, F., Qi, Y., Ma, L., Zhou, T., Li, Y., . . . Song, Z. (2019). Pegylated liposomal doxorubicin plus cyclophosphamide followed by docetaxel as neoadjuvant chemotherapy in locally advanced breast cancer (registration number: ChiCTR1900023052). Sci Rep.
Styl cytowania ChicagoLi, Ruoyang, et al. "Pegylated Liposomal Doxorubicin Plus Cyclophosphamide Followed By Docetaxel As Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer (registration Number: ChiCTR1900023052)." Sci Rep 2019.
Styl cytowania MLALi, Ruoyang, et al. "Pegylated Liposomal Doxorubicin Plus Cyclophosphamide Followed By Docetaxel As Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer (registration Number: ChiCTR1900023052)." Sci Rep 2019.
Uwaga: Te cytaty mogą odróżniać się od wytycznej twojego fakultetu..